| Stage | ICHR | % of rev | HUBG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $295M | 100.00% | $934M | 100.00% | HUBG ×3.17 |
| Gross profit | $41M | 13.90% | $791M | 84.69% | HUBG +70.8pp |
| Operating income | $7M | 2.44% | $39M | 4.22% | HUBG +1.8pp |
| Pre-tax income | $5M | 1.84% | $39M | 4.12% | HUBG +2.3pp |
| Net income | $998,000 | 0.34% | $29M | 3.10% | HUBG +2.8pp |
| Stage | ICHR | HUBG | Gap · A − B |
|---|---|---|---|
| Revenue | $295M100.00% | $934M100.00% | HUBG ×3.17 |
| Gross profit | 13.90%$41M | 84.69%$791M | HUBG +70.8pp |
| Operating income | 2.44%$7M | 4.22%$39M | HUBG +1.8pp |
| Pre-tax income | 1.84%$5M | 4.12%$39M | HUBG +2.3pp |
| Net income |
| 0.34%$998,000 |
| 3.10%$29M |
| HUBG +2.8pp |
No shared counterparties.